Omniscan Safety Update
General Electric (GE) has sent a letter to healthcare professionals in the United States referencing updated information that the FDA has posted on the link between certain gadolinium-based MRI contrast agents and Nephrogenic Fibrosing Dermopathy or Nephrogenic Systemic Fibrosis (NFD/NSF).
Click Here to read the letter on the GE website.